Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Caligiuri

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 6, 2020
Palladium(II)-η<sup>3</sup> -Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer TumoroidsThomas Scattolin, Enrica Bortolamiol, Fabiano Visentin, et al.
Cancers|October 31, 2020
Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery NanotoolsStefano Palazzolo, Lorenzo Memeo, Mohamad Hadla, et al.
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Androgen receptor serine 81 mediates Pin1 interaction and activityRaffaele La Montagna, Isabella Caligiuri, Pasquale Maranta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 12, 2015
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitorsCarlotta Granchi, Flavio Rizzolio, Vittorio Bordoni, et al.
Journal of Agricultural and Food Chemistry|June 24, 2017
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against CancerCarlotta Granchi, Serena Fortunato, Serena Meini, et al.
Journal of Advanced Research|August 9, 2025
Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responsesEnrico Cavarzerani, Isabella Caligiuri, Michele Bartoletti, et al.
ACS Omega|November 8, 2021
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)<sub>2</sub> NS) for Ovarian Cancer TherapyMuhammad Adeel, Salvatore Parisi, Matteo Mauceri, et al.
Cancers|September 28, 2021
STARD3: A Prospective Target for Cancer TherapyKanwal Asif, Lorenzo Memeo, Stefano Palazzolo, et al.
Journal of Cellular Physiology|June 3, 2015
Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer CellsVinit Kumar, Samer Bayda, Mohamad Hadla, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
First-of-its-kind STARD<sub>3</sub> Inhibitor: <i>In Silico</i> Identification and Biological Evaluation as Anticancer AgentMargherita Lapillo, Barbara Salis, Stefano Palazzolo, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 6, 2020
Palladium(II)-η<sup>3</sup> -Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer TumoroidsThomas Scattolin, Enrica Bortolamiol, Fabiano Visentin, et al.
Cancers|October 31, 2020
Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery NanotoolsStefano Palazzolo, Lorenzo Memeo, Mohamad Hadla, et al.
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Androgen receptor serine 81 mediates Pin1 interaction and activityRaffaele La Montagna, Isabella Caligiuri, Pasquale Maranta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 12, 2015
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitorsCarlotta Granchi, Flavio Rizzolio, Vittorio Bordoni, et al.
Journal of Agricultural and Food Chemistry|June 24, 2017
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against CancerCarlotta Granchi, Serena Fortunato, Serena Meini, et al.
Journal of Advanced Research|August 9, 2025
Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responsesEnrico Cavarzerani, Isabella Caligiuri, Michele Bartoletti, et al.
ACS Omega|November 8, 2021
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)<sub>2</sub> NS) for Ovarian Cancer TherapyMuhammad Adeel, Salvatore Parisi, Matteo Mauceri, et al.
Cancers|September 28, 2021
STARD3: A Prospective Target for Cancer TherapyKanwal Asif, Lorenzo Memeo, Stefano Palazzolo, et al.
Journal of Cellular Physiology|June 3, 2015
Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer CellsVinit Kumar, Samer Bayda, Mohamad Hadla, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
First-of-its-kind STARD<sub>3</sub> Inhibitor: <i>In Silico</i> Identification and Biological Evaluation as Anticancer AgentMargherita Lapillo, Barbara Salis, Stefano Palazzolo, et al.
Pageof 8